Skip to main content
SpringerLink
Log in

Cost-Effectiveness of Interventions for Children and Adolescents with Psychiatric Disorders

  • Chapter
  • First Online:
Book cover Mental Health Economics

  • 2183 Accesses

Abstract

The objective of this chapter is to provide an overview of the cost-effectiveness of interventions for the major burdensome mental health disorders occurring during childhood and adolescence: autism spectrum disorders, attention-deficit/hyperactivity disorder, and conduct disorders. Interventions in childhood have a great impact on society as a whole, not just the children and their families. The costs of psychiatric disorders in children and adolescents are reflected in education, justice, and productivity over their lifetime. However, cost-effectiveness evaluations of mental health interventions in children are more rare than in adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beecham J. Annual research review: child and adolescent mental health interventions: a review of progress in economic studies across different disorders. J Child Psychol Psychiatry. [Internet]. 2014 [cited 20 Nov 2016];55:714–32. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4657502&tool=pmcentrez&rendertype=abstract

  2. Suhrcke M, Pillas D, Selai C. Economic aspects of mental health in children and adolescents [Internet]. Who.backgr. Pap. 2007. p. 43–64. Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/76485/Hbsc_Forum_2007_economic_aspects.pdf

  3. Shah A, Jenkins R. Mental health economic studies from developing countries reviewed in the context of those from developed countries. Acta Psychiatr Scand [Internet]. 2000 [cited 11 Dec 2016];101:87–103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10706008

  4. Roberts RE, Attkisson CC, Rosenblatt A. Prevalence of psychopathology among children and adolescents. Am J Psychiatry [Internet]. 1998 [cited 20 Nov 2016];155:715–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9619142

  5. Skovgaard AM. Mental health problems and psychopathology in infancy and early childhood. An epidemiological study. Dan Med Bull [Internet]. 2010 [cited 11 Dec 2016];57:B4193. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21040689

  6. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol [Internet]. 2011 [cited 11 Dec 2016];21:718–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21924589

  7. Barrett B, Byford S, Chitsabesan P, Kenning C. Mental health provision for young offenders: service use and cost. Br J Psychiatry [Internet]. 2006 [cited 11 Dec 2016];188:541–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16738344

  8. Minnis H, Everett K, Pelosi AJ, Dunn J, Knapp M. Children in foster care: mental health, service use and costs. Eur Child Adolesc Psychiatry [Internet]. 2006 [cited 11 Dec 2016];15:63–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16523249

  9. Romeo R, Knapp M, Scott S. Economic cost of severe antisocial behaviour in children – and who pays it. Br J Psychiatry [Internet]. 2006 [cited 10 Oct 2016];188:547–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16738345

  10. Clark AF, O’Malley A, Woodham A, Barrett B, Byford S. Children with complex mental health problems: needs, costs and predictors over one year. Child Adolesc Ment Health [Internet]. 2005 [cited 11 Dec 2016];10:170–8. Available from: http://doi.wiley.com/10.1111/j.1475-3588.2005.00349.x

  11. Muntz R, Hutchings J, Edwards R-T, Hounsome B, O’Céilleachair A. Economic evaluation of treatments for children with severe behavioural problems. J Ment Health Policy Econ [Internet]. 2004 [cited 11 Dec 2016];7:177–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15701933

  12. Järbrink K, Fombonne E, Knapp M. Measuring the parental, service and cost impacts of children with autistic spectrum disorder: a pilot study. J Autism Dev Disord [Internet]. 2003 [cited 11 Dec 2016];33:395–402. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12959418

  13. Beecham J, Chadwick O, Fidan D, Bernard S. Children with severe learning disabilities: needs, services and costs. Child. Soc. [Internet]. 2002 [cited 11 Dec 2016];16:168–81. Available from: http://doi.wiley.com/10.1002/chi.690

  14. Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B. Client socio-demographic and service receipt inventory – European version: development of an instrument for international research. EPSILON Study 5. European psychiatric services: inputs linked to outcome domains and needs. Br. J. Psychiatry. Suppl. [Internet]. 2000 [cited 22 Nov 2014];s28–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10945075

  15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Press; 2013.

    Book  Google Scholar 

  16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th-Revise ed. Washington, DC: APA; 2000.

    Google Scholar 

  17. Center for Disease Control and Prevention. Autism spectrum disorder (ASD) [Internet]. 2016. Available from: http://www.cdc.gov/ncbddd/autism/index.html

  18. Mandell DS, Morales KH, Xie M, Lawer LJ, Stahmer AC, Marcus SC. Age of diagnosis among medicaid-enrolled children with autism, 2001–2004. Psychiatr. Serv. [Internet]. 2010 [cited 17 Dec 2016];61:822–9. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2966012&tool=pmcentrez&rendertype=abstract

  19. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual. Life Outcomes [Internet]. 2003 [cited 18 Dec 2016];1:54. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=293474&tool=pmcentrez&rendertype=abstract

  20. Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual. Life Res. [Internet]. 2010 [cited 18 Dec 2016];19:875–86. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2892611&tool=pmcentrez&rendertype=abstract

  21. Stevens K. The child health utility 9D (CHU9D). A new, paediatric, preference-based measure of health related quality of life. Patient Rep. Outcomes [Internet]. Lyon; 2010;43:11–2. Available from: http://www.pro-newsletter.com/images/PDF/pron43-final.pdf

  22. National Collaborating Centre for Mental Health. Autism: the management and support of children and young people on the autism spectrum. [Internet]. Nice Clinical Guidelines, editor. Leicester: British Psychological Society; 2013. Available from: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0078143/

  23. Payakachat N, Tilford JM, Kovacs E, Kuhlthau K. Autism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applications. Expert Rev. Pharmacoecon. Outcomes Res. [Internet]. 2012 [cited 17 Dec 2016];12:485–503. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3502071&tool=pmcentrez&rendertype=abstract

  24. Rogers SJ, Vismara LA. Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol. 2010;37:8–38.

    Article  Google Scholar 

  25. Horlin C, Falkmer M, Parsons R, Albrecht MA, Falkmer T. The cost of autism spectrum disorders. PLoS One [Internet]. 2014 [cited 27 Nov 2016];9:e106552. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4156354&tool=pmcentrez&rendertype=abstract

  26. Allen-Meares P, MacDonald M, McGee K. Autism spectrum disorder updates – relevant information for early interventionists to consider. Front. Public Health. [Internet]. 2016 [cited 1 Dec 2016];4:236. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=5083851&tool=pmcentrez&rendertype=abstract

  27. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the early start Denver Model. Pediatrics [Internet]. 2010 [cited 29 Nov 2016];125:e17–23. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4951085&tool=pmcentrez&rendertype=abstract

  28. Chasson GS, Harris GE, Neely WJ. Cost comparison of early intensive behavioral intervention and special education for children with autism. J. Child Fam. Stud. [Internet]. 2007;16:401–13. Available from: http://dx.doi.org/10.1007/s10826-006-9094-1

  29. Motiwala SS, Gupta S, Lilly MB, Ungar WJ, Coyte PC. The cost-effectiveness of expanding intensive behavioural intervention to all autistic children in Ontario: in the past year, several court cases have been brought against provincial governments to increase funding for Intensive Behavioural Intervention. Healthc. Policy [Internet]. 2006 [cited 18 Dec 2016];1:135–51. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2585334&tool=pmcentrez&rendertype=abstract

  30. Penner M, Rayar M, Bashir N, Roberts SW, Hancock-Howard RL, Coyte PC. Cost-effectiveness analysis comparing pre-diagnosis autism spectrum disorder (ASD)-targeted intervention with Ontario’s autism intervention program. J. Autism Dev. Disord. [Internet]. 2015 [cited 17 Dec 2016];45:2833–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25936527

  31. Farmer C, Thurm A, Grant P. Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs [Internet]. 2013 [cited 17 Dec 2016];73:303–14. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3632301&tool=pmcentrez&rendertype=abstract

  32. Accordino RE, Kidd C, Politte LC, Henry CA, McDougle CJ. Psychopharmacological interventions in autism spectrum disorder. Expert Opin. Pharmacother. [Internet]. 2016 [cited 27 Nov 2016];17:937–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26891879

  33. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry [Internet]. 2007 [cited 27 Nov 2016];164:942–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17541055

  34. Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics [Internet]. 2015 [cited 18 Dec 2016];135:e994–1001. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25733754

  35. Küpper T, Haavik J, Drexler H, Ramos-Quiroga JA, Wermelskirchen D, Prutz C, et al. The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents. Int. Arch. Occup. Environ. Health [Internet]. 2012 [cited 18 Dec 2016];85:837–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22752312

  36. Dalsgaard S, Østergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. London [Internet]. 2015 [cited 18 Dec 2016];385:2190–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25726514

  37. Wu EQ, Hodgkins P, Ben-Hamadi R, Setyawan J, Xie J, Sikirica V, et al. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review. CNS Drugs [Internet]. 2012 [cited 20 Dec 2016];26:581–600. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22712698

  38. Catalá-López F, Ridao M, Sanfélix-Gimeno G, Peiró S. Cost-effectiveness of pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: qualitative synthesis of scientific evidence. Rev. Psiquiatr. Salud Ment. [Internet]. [cited 20 Nov 2016];6:168–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23453596

  39. Sikirica V, Haim Erder M, Xie J, Macaulay D, Diener M, Hodgkins P, et al. Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents. Pharmacoeconomics [Internet]. 2012 [cited 18 Dec 2016];30:e1–15. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3576910&tool=pmcentrez&rendertype=abstract

  40. Foster EM, Jensen PS, Schlander M, Pelham WE, Hechtman L, Arnold LE, et al. Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv. Res. [Internet]. 2007 [cited 18 Dec 2016];42:165–82. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955245&tool=pmcentrez&rendertype=abstract

  41. Gilmore A, Milne R. Methylphenidate in children with hyperactivity: review and cost-utility analysis. Pharmacoepidemiol. Drug Saf. [Internet]. [cited 18 Dec 2016];10:85–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11499858

  42. Dretzke J, Frew E, Davenport C, Barlow J, Stewart-Brown S, Sandercock J, et al. The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children. Health Technol. Assess. [Internet]. 2005 [cited 20 Nov 2016];9:iii, ix–x, 1–233. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16336845

  43. Foster EM, Jones DE. The high costs of aggression: public expenditures resulting from conduct disorder. Am. J. Public Health [Internet]. 2005 [cited 19 Dec 2016];95:1767–72. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1449434&tool=pmcentrez&rendertype=abstract

  44. Foster EM, Jones D. Can a costly intervention be cost-effective?: An analysis of violence prevention. Arch. Gen. Psychiatry [Internet]. 2006 [cited 27 Nov 2016];63:1284–91. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2753445&tool=pmcentrez&rendertype=abstract

  45. Furlong M, McGilloway S, Bywater T, Hutchings J, Smith SM, Donnelly M. Cochrane review: behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years (Review). Evid. Based. Child Health [Internet]. 2013 [cited 27 Nov 2016];8:318–692. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23877886

  46. Edwards RT, Céilleachair A, Bywater T, Hughes DA, Hutchings J. Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis. BMJ [Internet]. 2007 [cited 20 Nov 2016];334:682. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1839236&tool=pmcentrez&rendertype=abstract

  47. O’Neill D, McGilloway S, Donnelly M, Bywater T, Kelly P. A cost-effectiveness analysis of the incredible years parenting programme in reducing childhood health inequalities. Eur J Health Econ [Internet]. 2013;14:85–94. Available from: http://dx.doi.org/10.1007/s10198-011-0342-y

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre of Economic Mental Health, Department of Psychiatry, Universidade Federal de Sao Paulo, Rua Borges Lagoa 570, 1° andar, São Paulo, 04038-000, Brazil

    Monica Kayo

Authors
  1. Monica Kayo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica Kayo .

Editor information

Editors and Affiliations

  1. Centre of Economic Mental Health, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil

    Denise Razzouk

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Kayo, M. (2017). Cost-Effectiveness of Interventions for Children and Adolescents with Psychiatric Disorders. In: Razzouk, D. (eds) Mental Health Economics. Springer, Cham. https://doi.org/10.1007/978-3-319-55266-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55266-8_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55265-1

  • Online ISBN: 978-3-319-55266-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation